BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30850054)

  • 1. Analysis of modification and proteolytic targeting by the ubiquitin-like modifier FAT10.
    Aichem A; Boehm AN; Catone N; Schmidtke G; Groettrup M
    Methods Enzymol; 2019; 618():229-256. PubMed ID: 30850054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
    Aichem A; Anders S; Catone N; Rößler P; Stotz S; Berg A; Schwab R; Scheuermann S; Bialas J; Schütz-Stoffregen MC; Schmidtke G; Peter C; Groettrup M; Wiesner S
    Nat Commun; 2018 Aug; 9(1):3321. PubMed ID: 30127417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
    Bialas J; Groettrup M; Aichem A
    PLoS One; 2015; 10(3):e0120329. PubMed ID: 25768649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-like modifier FAT10 inhibits retinal PDE6 activity and mediates its proteasomal degradation.
    Boehm AN; Bialas J; Catone N; Sacristan-Reviriego A; van der Spuy J; Groettrup M; Aichem A
    J Biol Chem; 2020 Oct; 295(42):14402-14418. PubMed ID: 32817338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAT10ylation as a signal for proteasomal degradation.
    Schmidtke G; Aichem A; Groettrup M
    Biochim Biophys Acta; 2014 Jan; 1843(1):97-102. PubMed ID: 23333871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1.
    Aichem A; Catone N; Groettrup M
    FEBS J; 2014 Apr; 281(7):1848-59. PubMed ID: 24528925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10.
    Schmidtke G; Kalveram B; Weber E; Bochtler P; Lukasiak S; Hipp MS; Groettrup M
    J Biol Chem; 2006 Jul; 281(29):20045-54. PubMed ID: 16707496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin-like modifier FAT10 covalently modifies HUWE1 and strengthens the interaction of AMBRA1 and HUWE1.
    Mueller S; Bialas J; Ryu S; Catone N; Aichem A
    PLoS One; 2023; 18(8):e0290002. PubMed ID: 37578983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkin is an E3 ligase for the ubiquitin-like modifier FAT10, which inhibits Parkin activation and mitophagy.
    Roverato ND; Sailer C; Catone N; Aichem A; Stengel F; Groettrup M
    Cell Rep; 2021 Mar; 34(11):108857. PubMed ID: 33730565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition.
    Kalveram B; Schmidtke G; Groettrup M
    J Cell Sci; 2008 Dec; 121(Pt 24):4079-88. PubMed ID: 19033385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAT10 and NUB1L cooperate to activate the 26S proteasome.
    Brockmann F; Catone N; Wünsch C; Offensperger F; Scheffner M; Schmidtke G; Aichem A
    Life Sci Alliance; 2023 Aug; 6(8):. PubMed ID: 37188463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
    Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
    Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
    Schmidtke G; Kalveram B; Groettrup M
    FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
    Bialas J; Boehm AN; Catone N; Aichem A; Groettrup M
    J Biol Chem; 2019 Mar; 294(12):4315-4330. PubMed ID: 30718280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin-like modifier FAT10 is degraded by the 20S proteasome in vitro but not in cellulo.
    Oliveri F; Keller SJ; Goebel H; Alvarez Salinas GO; Basler M
    Life Sci Alliance; 2023 Jun; 6(6):. PubMed ID: 37012049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-like modifier FAT10 - much more than a proteasome-targeting signal.
    Aichem A; Groettrup M
    J Cell Sci; 2020 Jul; 133(14):. PubMed ID: 32719056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAT10, a ubiquitin-independent signal for proteasomal degradation.
    Hipp MS; Kalveram B; Raasi S; Groettrup M; Schmidtke G
    Mol Cell Biol; 2005 May; 25(9):3483-91. PubMed ID: 15831455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAT10 and NUB1L bind to the VWA domain of Rpn10 and Rpn1 to enable proteasome-mediated proteolysis.
    Rani N; Aichem A; Schmidtke G; Kreft SG; Groettrup M
    Nat Commun; 2012 Mar; 3():749. PubMed ID: 22434192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.
    Aichem A; Pelzer C; Lukasiak S; Kalveram B; Sheppard PW; Rani N; Schmidtke G; Groettrup M
    Nat Commun; 2010 May; 1():13. PubMed ID: 20975683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination.
    Buchsbaum S; Bercovich B; Ciechanover A
    Mol Biol Cell; 2012 Jan; 23(1):225-32. PubMed ID: 22072791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.